Table 2. Comparison of period prevalence and detection rate estimates with other similar estimates in literature [44, 45].

		Other Estimates [44, 45]		This Study’s Estimates
Date	Country	Estimated Period Prevalence [95% CI]	Estimated Detection Rate [95% CI]	Estimated Period Prevalence	Estimated Detection Rate
		% of total population	% of infections	% of total population	% of infections
14 April 2020 [44]	Australia	0.04 [0.03–0.09]	59 [28–90]	0.03	88
	Canada	1.0 [0.67–2.2]	6.7 [3.1–10]	0.44	21
	South Korea	0.06 [0.04–0.13]	35 [16–53]	0.06	33
	USA	2.6 [1.7–5.6]	6.8 [3.2–10]	1.6	14
4 May 2020 [45]	Austria	0.76 [0.59–0.98]	23.4 [18–30]	1.0	17
	Belgium	8.0 [6.1–11]	5.4 [3.9–7.1]	12.3	3.5
	Denmark	1.0 [0.81–1.4]	17 [12–21]	0.95	17
	France	3.4 [2.7–4.3]	7.6 [6.0–9.6]	5.9	4.3
	Germany	0.85 [0.66–1.1]	23 [18–30]	1.1	18
	Italy	4.6 [3.6–5.8]	7.5 [6.0–9.6]	8.0	4.3
	Norway	0.46 [0.34–0.61]	32 [24–44]	0.52	28
	Spain	5.5 [4.4–7.0]	9.6 [7.5–12]	7.7	6.8
	Sweden	3.7 [2.8–5.1]	6.0 [4.4–8.0]	3.0	7.4
	Switzerland	1.9 [1.5–2.4]	18 [14–23]	3.1	11
	UK	5.1 [4.0–6.5]	5.3 [4.2–6.8]	5.4	4.9